# MUTUAL NON-DISCLOSURE AGREEMENT
## For Technology Evaluation and Demonstration

**CONFIDENTIAL - PATENT PENDING TECHNOLOGY**

---

**This Mutual Non-Disclosure Agreement** ("Agreement") is entered into as of ________________, 2025 ("Effective Date") by and between:

**DISCLOSING PARTY:**
- **Name:** Envision Connect
- **Address:** [Your Address]
- **Representative:** [Your Name], [Title]

**RECEIVING PARTY:**
- **Hospital/Organization:** ______________________________
- **Address:** _______________________________________
- **Representative:** _________________, [Title]

---

## 1. PURPOSE

The parties wish to explore a potential business relationship regarding Envision Connect's proprietary healthcare technology platform, including but not limited to:

- **AI-Powered EHR Auto-Detection System** (Patent Pending)
- Universal Healthcare Integration Architecture
- Multi-tenant white-label platform
- FHIR/HL7 adapter technology
- Healthcare data integration methods

The Disclosing Party will share proprietary technical information, demonstrations, and confidential business information with the Receiving Party for evaluation purposes only.

---

## 2. CONFIDENTIAL INFORMATION

"Confidential Information" includes:

### Technical Information:
- Software architecture and design patterns
- AI-powered vendor detection algorithms
- Automatic adapter configuration methods
- FHIR metadata interrogation techniques
- Database schemas and data models
- Source code, APIs, and integration methods
- Security and compliance implementations

### Business Information:
- Pricing models and business strategies
- Customer lists and hospital partnerships
- Marketing materials and business plans
- Product roadmaps and feature plans

### Demonstration Materials:
- Live system demonstrations
- Screenshots and technical documentation
- Configuration examples and setup guides
- Performance metrics and test results

**Excluded Information:**
Information that is:
1. Publicly known at time of disclosure
2. Independently developed by Receiving Party
3. Rightfully obtained from third parties
4. Required by law to be disclosed (with prior notice)

---

## 3. OBLIGATIONS OF RECEIVING PARTY

The Receiving Party agrees to:

1. **Maintain Confidentiality:** Use the same degree of care (but no less than reasonable care) to protect Confidential Information as it uses for its own confidential information.

2. **Limited Use:** Use Confidential Information solely for evaluating the potential business relationship with Disclosing Party.

3. **No Copying:** Not copy, reverse engineer, decompile, or attempt to derive the source code or underlying ideas, algorithms, or structure of any software or technical materials.

4. **Restricted Disclosure:** Limit disclosure to employees, contractors, or advisors who:
   - Have a legitimate need to know
   - Are bound by confidentiality obligations at least as restrictive as this Agreement
   - Understand the confidential nature of the information

5. **No Competitive Use:** Not use Confidential Information to develop competing products or services.

---

## 4. PATENT PENDING TECHNOLOGY

The Receiving Party acknowledges that:

1. Envision Connect has filed or intends to file patent applications covering:
   - AI-powered EHR system auto-detection methods
   - Universal healthcare integration adapter architecture
   - Intelligent configuration and troubleshooting systems
   - Multi-protocol healthcare data integration methods

2. Demonstration of these technologies does not constitute:
   - A license to use, make, or sell the patented inventions
   - Public disclosure that would affect patent rights
   - Permission to file competing patent applications

3. The Receiving Party will not:
   - File patent applications related to the demonstrated technology
   - Claim ownership of any ideas, methods, or implementations shown
   - Challenge the validity of any patents or patent applications

---

## 5. INTELLECTUAL PROPERTY

All Confidential Information remains the sole property of the Disclosing Party. No license or right to Confidential Information is granted except the limited right to evaluate for the stated purpose.

**No Implied Rights:**
- This Agreement does not grant any license under any patents, copyrights, trademarks, or trade secrets
- All intellectual property rights remain with the Disclosing Party
- No joint ownership is created by disclosure or collaboration

---

## 6. TERM AND TERMINATION

**Term:** This Agreement begins on the Effective Date and continues for **3 years**.

**Survival:** Obligations regarding Confidential Information survive termination for:
- **5 years** for trade secrets
- **3 years** for other confidential information

**Return of Materials:** Upon request or termination, Receiving Party will:
- Return or destroy all Confidential Information
- Certify in writing that all materials have been returned or destroyed
- Permanently delete any electronic copies

---

## 7. NO WARRANTY

Confidential Information is provided "AS IS" without warranty of any kind. The Disclosing Party makes no representations regarding:
- Accuracy or completeness of information
- Non-infringement of third-party rights
- Fitness for a particular purpose

---

## 8. REMEDIES

The parties acknowledge that:

1. **Irreparable Harm:** Breach of this Agreement may cause irreparable harm for which monetary damages are inadequate.

2. **Injunctive Relief:** The Disclosing Party is entitled to seek injunctive relief, specific performance, or other equitable remedies without posting bond.

3. **Attorney's Fees:** Prevailing party in any litigation is entitled to reasonable attorney's fees and costs.

---

## 9. GENERAL PROVISIONS

**Governing Law:** This Agreement is governed by the laws of [Your State], without regard to conflict of law principles.

**Entire Agreement:** This Agreement constitutes the entire agreement regarding confidentiality and supersedes all prior agreements.

**Amendment:** Any amendments must be in writing and signed by both parties.

**Severability:** If any provision is found invalid, the remaining provisions continue in full force.

**No Partnership:** This Agreement does not create a partnership, joint venture, or agency relationship.

**Counterparts:** This Agreement may be executed in counterparts, each of which is an original.

---

## SIGNATURES

**DISCLOSING PARTY: Envision Connect**

Signature: _________________________________

Name: ____________________________________

Title: ____________________________________

Date: ____________________________________


**RECEIVING PARTY: [Hospital/Organization Name]**

Signature: _________________________________

Name: ____________________________________

Title: ____________________________________

Date: ____________________________________

---

**WITNESS (Optional but Recommended):**

Signature: _________________________________

Name: ____________________________________

Date: ____________________________________

---

## EXHIBIT A: PERMITTED ATTENDEES

The following individuals are authorized to receive Confidential Information under this Agreement:

**From Envision Connect:**
1. _______________________________ (Name, Title)
2. _______________________________ (Name, Title)

**From [Hospital/Organization]:**
1. _______________________________ (Name, Title)
2. _______________________________ (Name, Title)
3. _______________________________ (Name, Title)

Additional attendees must be approved in writing by both parties.

---

**END OF AGREEMENT**

---

## üìã INSTRUCTIONS FOR USE

### Before the Hospital Meeting:

1. **Fill in your information** (name, address, title)
2. **Send to hospital contact** at least **48 hours before meeting**
3. **Request IT Director signature** (not just meeting coordinator)
4. **Get signed copy back** before you demo anything
5. **Keep original** in safe place

### During the Meeting:

1. **Confirm NDA is signed** before starting demo
2. **Reference it at start:** "As covered in our NDA, this is patent-pending technology..."
3. **Mark all materials** "Confidential - Patent Pending"
4. **List attendees** in Exhibit A
5. **Don't provide source code** or detailed implementation

### After the Meeting:

1. **Follow up in writing** referencing NDA
2. **Mark all emails** "Confidential per NDA dated [date]"
3. **Keep records** of what was disclosed
4. **Document conversations** about your technology

---

## ‚ö†Ô∏è LEGAL DISCLAIMER

**This template is provided for informational purposes only and does not constitute legal advice.

Consult with a qualified attorney licensed in your jurisdiction before using this NDA. Healthcare technology involves complex intellectual property issues, and professional legal review is strongly recommended.**

---

**¬© 2025 Envision Connect. All Rights Reserved.**
*Patent Pending Technology*
